Man holds Aus notes

4DMedical reportedly raising $150M at $3.80/sh; ASX 200 inclusion possible

4DMedical has startled some HotCopper forum users as it stages a $150 million capital raising at…
FDA Approval

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor has won its first keystone FDA clearance, with the U.S. regulator effectively thumbs-upping Imricor's diagnostic…
Australian currency cash

Mesoblast back to record highs as Ryoncil sales jump 60% QoQ to US$35M

Mesoblast is back onto investors' radars with good tidings from its sale of Ryoncil, with that…
AI image of a lung cross section

4DX up another 15% on new demo delivery; now boasting $2.5B cap & no revenue

4DMedical has climbed to a lofty valuation just short of $4.80 on Wednesday, bringing the biotech…
Knee joint injection with hyaluronic acid for osteoarthritis treatment. Medical procedure using syringe in sterile hospital environment. Professional orthopedic therapy for joint pain relief.

Paradigm Biopharma rolls into CY26 on patient tailwinds after hitting 25% recruitment milestone

Late-stage drug developer Paradigm Biopharmaceuticals is preparing for a huge CY26 after landing a key recruitment…
Memphasys (ASX:MEM) Felix™ System

Memphasys locks down 5-year European IVF supply deal

Memphasys has this week executed a long-term European commercial supply agreement with Centro Fertilita Assistita (CFA)…
The Market Online Video

Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie

From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer…
Lung imaging concept

Biotech lung imaging darling 4DX Medical back at $2.20/sh on Miami U contract

4DX Medical has seen its price jump back to $2.20/sh, as its next-gen lung imaging scan…
Chuffed bloke

Race Oncology’s placement-at-a-premium rewarded as shares jump +8%

Race Oncology has completed its recent A$3.2M placement – something that shareholders on the HotCopper forums…

Effective as an IV drug, a gel, and now an inhaler – Recce’s R327 can’t stop winning

Recce flagship antibacertial and anti-infective drug R327 has in a model that shows the drug could…